Brian Palan v. Inovio Pharmaceuticals Inc

653 F. App'x 97
CourtCourt of Appeals for the Third Circuit
DecidedJune 23, 2016
Docket15-3327
StatusUnpublished
Cited by4 cases

This text of 653 F. App'x 97 (Brian Palan v. Inovio Pharmaceuticals Inc) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Brian Palan v. Inovio Pharmaceuticals Inc, 653 F. App'x 97 (3d Cir. 2016).

Opinion

OPINION *

VAN ANTWERPEN, Circuit Judge.

Brian Palan appeals the final decision of the U.S. District Court for the Eastern District of Pennsylvania granting summary judgment in favor of his former employer, Inovio Pharmaceuticals Inc., and some of its employees (collectively “Ino-vio”). For the following reasons, we will affirm the decision of the District Court.

*99 I.

From November 1, 2010, until his termination on July 16, 2014, Palan was employed as Inovio’s full-time Information Technology (“IT”) Manager. (A60, A167). In his capacity as the company’s only IT employee, Palan states that he was responsible for “managing the IT environment, overseeing the day-to-day operations of IT, helping end users, and helping with office moves.” (Id.). In April 2014, Palan was diagnosed with diverticulitis. (Id. at A61). While Palan sought non-surgical treatment alternatives, two doctors advised him that urgent surgery was medically necessary. (Id.).

On May 16, 2014, Palan scheduled his surgery for May 28, 2014, and advised Thomas Kim, Inovio’s General Counsel and Corporate Secretary; Peter Kies, Ino-vio’s Chief Financial Officer; and Jeffrey Richardson, Inovio’s Senior Director of External Affairs, of his plans. (Id. at A163-A164, A166). Palan also stated that he would need to take four to six weeks of leave, with his last day of work on May 23rd, for the surgery and expected recovery time. (Id. at A166). Prior to his scheduled leave, to which Inovio had no objections, Palan met with Richardson to “discuss his medical leave and to obtain information regarding short-term disability benefits.” (Id. at A62) (internal quotation marks omitted). It is undisputed, as Palan testified at his deposition, that neither at this meeting, nor at any other time, did any Inovio employee mention the Family Medical Leave Act (“FMLA”) leave. (Id. at A63). While on leave, Palan relayed to Inovio that he planned to return to work on or around July 16th. (Id. at A167). On that date, prior to his return to work, Richardson and Kim informed Palan that he was terminated. (Id.).

In his amended complaint, Palan brought interference and retaliation claims under the FMLA, 29 U.S.C. §§ 2601-2664. (A162-A171). The District Court (Beetle-stone, J.), granted Inovio’s Motion for Summary Judgment on both claims. (Al-A9). The District Court denied Palan’s Motion for Reconsideration in a one-page order without an opinion. (A10). This timely appeal of both the order granting summary judgment and the order denying reconsideration followed. (All).

II. 1

We exercise de novo review over a grant of summary judgment. 2 Macfarlan v. Ivy Hill SNF, LLC, 676 F.3d 266, 271 (3d Cir.2012). Summary judgment is appropriate if the moving party has shown that the evidentiary material on the record, if reduced to admissible evidence, is insufficient to permit the nonmoving party to carry its burden of proof, and there are no disputes as to issues of material fact. 3 Celo- *100 tex Corp. v. Catrett, 477 U.S. 317, 322-23, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986).

The FMLA allows “eligible employeefs]” to take “a total of 12 workweeks of leave during any 12-month period” for, inter alia, “a serious health condition that makes the employee unable to perform the functions of the position of such employee.” 4 29 U.S.C. § 2612(a)(1)(D). Eligible employees may bring a FMLA claim if an employer interferes with their rights under the FMLA, as well as if an employer discharges an employee who has taken leave protected under the FMLA. See id. § 2615(a)(1) & (2).

The doctrine of equitable estoppel “seeks to prevent injustice when an individual detrimentally and predictably relies on the misrepresentation of another.” Nagle v. Acton-Boxborough Reg’l Sch. Dist., 576 F.3d 1, 3 (1st Cir.2009). A party seeking to invoke equitable estoppel must establish three elements: “(1) a misrepresentation by another party; (2) which [the party] reasonably relied upon; (3) to [the party’s] detriment.” United States v. Asmar, 827 F.2d 907, 912 (3d Cir.1987); see Heckler v. Cmty. Health Servs. of Crawford Cty., Inc., 467 U.S. 51, 59-61, 104 S.Ct. 2218, 81 L.Ed.2d 42 (1984); In re RFE Indus., Inc., 283 F.3d 159, 164 (3d Cir.2002). In a nonprecedential opinion, we held that equitable estoppel can apply to FMLA claims to bar an employer from raising an employee’s non-eligibility as a defense. Leese v. Adelphoi Vill., Inc., 516 Fed.Appx. 192, 193 (3d Cir.2013). In doing so, we joined a number of our sister circuits who have recognized the availability of this doctrine in the FMLA context. 5 Id. at 193-94.

It is undisputed that Palan is not an eligible employee under the FMLA. (A4). Inovio was not required to provide FMLA protection at any time relevant to the instant action because it employed fewer than the required fifty employees within a seventy-five mile radius of the worksite. See 29 U.S.C. § 2611(2)(B)(ii). Palan argues that because Inovio voluntarily implemented a FMLA policy as evidenced by the company handbook, they were equitably estopped from denying him the Act’s protections. (Appellant’s Br. 5-6). Inovio maintains that it terminated Palan not for taking leave, but rather to employ a higher-level IT Director. (Appellee’s Br. 7 n.2). The company’s IT needs, as well as issues with Palan’s performance, which were highlighted during the company’s relocation while Palan was on leave, spurred this decision. 6 (Id.); (A34-A37).

*101 A. Misrepresentation of Fact

The first element necessary to establish equitable estoppel requires a “definite misrepresentation,” but need not entail the intent to deceive. Minard v. ITC Deltacom Commc’ns, Inc.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
653 F. App'x 97, Counsel Stack Legal Research, https://law.counselstack.com/opinion/brian-palan-v-inovio-pharmaceuticals-inc-ca3-2016.